Skin Replacements and Substitutes | Market Insights | US | 2019
Although favorable demographics and the launch of innovative new products will drive continued growth in the US market for skin replacements and substitutes, challenges in the biologic product segment, with some private insurers ceasing to cover higher-priced amniotic allografts, will hinder market expansion to some extent.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for skin replacements and substitutes in the US across a 10-year period.